PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

CVR 33242840 · Private limited company (ApS) · Active · Low risk

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 16 annual reports have been published, of which 6 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 23.9m and a net result of DKK 3.1m. CEO: Thomas Noel O´Leary.

Bankruptcy risk for PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 38% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
33242840
Status
Active
Company type
Private limited company (ApS)
Founded
(16 years)
Address
c/o KELLER Advokater, Strandvejen 102B, 5. tv
2900 Hellerup
Municipality
Gentofte
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 80k
Employees
29 (2018)
Auditor
BDO Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late6 of 16
Missing annual reportNo
Negative equityNo
Equity ratio50.6%
Current ratio202%
Moves (last 2 years)2
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address182
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 61.6mDKK 72.3mDKK 64.0m
Net profitDKK 3.1mDKK 3.6mDKK 3.1m
EquityDKK 23.9mDKK 20.9mDKK 17.3m
Total assetsDKK 47.3mDKK 46.6mDKK 39.0m
CashDKK 2.4mDKK 3.5m–
Short-term debtDKK 23.4mDKK 25.7m–
Tax owedDKK 208kDKK 641k–
Avg. employees5872–

Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · BDO Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025188 Late
1 Jan 2024 – 31 Dec 2024181
1 Jan 2023 – 31 Dec 2023173
1 Jan 2022 – 31 Dec 2022220 Late
1 Jan 2021 – 31 Dec 2021188 Late
1 Jan 2020 – 31 Dec 2020214 Late
1 Jan 2019 – 31 Dec 2019246 Late
1 Jan 2018 – 31 Dec 2018181
1 Jan 2017 – 31 Dec 2017150
1 Jan 2016 – 31 Dec 2016177
1 Jan 2015 – 31 Dec 2015183
1 Jan 2014 – 31 Dec 2014187 Late
1 Jan 2013 – 31 Dec 2013168
1 Jan 2012 – 31 Dec 2012170
1 Jan 2011 – 31 Dec 2011153
7 Oct 2010 – 31 Dec 2010181

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOThomas Noel O´LearyCurrent
CEOColin Shannon
CEORobert James Leftwich
BoardSimon Peter HollywoodCurrent
BoardJohn SheahanCurrent
BoardThomas Noel O´LearyCurrent
BoardColin Shannon
BoardChristopher John Gray
BoardSusan Caroline Stansfield
BoardTimothy Jon McClain
BoardRobert James Leftwich
Owner (100%)ICON CLINICAL (UK) LIMITEDCurrent
AuditorBDO Statsautoriseret RevisionspartnerselskabCurrent
AuditorBDO Holding VII, statsautoriseret revisionsaktieselskab
FounderPharm Research Associates (UK) LimitedCurrent

Address history (4 moves)

c/o KELLER Advokater, Strandvejen 102B, 5. tv, 2900 Hellerup
c/o Keller Advokatfirma, H.C. Andersens Boulevard 48, 1., 1553 København V
c/o BuusMark Advokater, Sankt Ols Gade 4, 4000 Roskilde
c/o BDO, Havneholmen 29, 1561 København V
c/o Dander & More, Lautrupsgade 7, 2100 København Ø

Employees per year

Number of employees at PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS per year16322011: 220112012: 320122013: 520132014: 620142015: 2020152016: 2820162017: 3220172018: 292018

Other companies at the same address

Similar companies in Gentofte

Questions and answers about PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

Has PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS gone bankrupt?

No, PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS?

Thomas Noel O´Leary is the CEO of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS.

Who is the auditor of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS?

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS most recently used BDO Statsautoriseret Revisionspartnerselskab.

When was PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS founded?

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS was founded on 7 October 2010.

What is the equity of PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS?

Equity was DKK 23.9m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.